LATEST PSYCHEDELICS STOCKS NEWS

115 views16 min read

Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies

Field Trip Health
Transaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next generation psychedelic therapies. Shareholders of Field Trip will receive shares of each company. Company to host a conference call on Friday, April 29, 2022 at 8:30 a.m. ET. TORONTO, April 28, ... Read More...
114 views5 min read

Optimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility

Optimi Health
VANCOUVER, British Columbia, April 28, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it will be inaugurating its recently completed psilocybin cultivation facility with a grand opening event and reception for members of the media, investors and other stakeholders... Read More...
873 views8 min read

Allied Corp Announces Initial US$147,000 Purchase Order Continuing into Monthly Supply Agreement for Brazilian Specialty Cancer Care Hospital

Allied
KELOWNA, British Columbia, April 27, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce the signing of a forward purchase agreement with a distributor for a specialty medical care hospital (the “Brazilian Group”) based out of Sao Paulo, Brazil. Under this agreement, the Brazilian Group will initially pur... Read More...
Financials666 views1 min read

MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2022

Mind Cure Health
VANCOUVER, BC, April 26, 2022 - Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) ("MINDCURE") today announced its financial results for the three and nine months ended February 28, 2022.  All amounts are stated in Canadian dollars unless otherwise indicated.   A copy of the Company's financial statements for the three and nine ... Read More...
Joint Venture369 views7 min read

Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

Cybin
TORONTO, April 21, 2022--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing "Psychedelics to TherapeuticsTM", today announced that it has partnered with Clinilabs Drug Development Corporation ("Clinilabs"), a global, full-service contract research organiza... Read More...
868 views8 min read

Allied Corp. Announces Initiation of Its First Three Major Commercial Exports of Cannabis Flower From Colombia to International Markets

Allied
KELOWNA, British Columbia, April 21, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has initiated three major commercial exports of Colombian-produced dried cannabis flower. One export is intended for Australia, and the other two exports are intended for the United States. The starting export... Read More...
Calendar671 views3 min read

Bright Minds Biosciences to Host Symposium on Therapeutic Developments within Dravet Syndrome and Featuring a Panel with Key Opinion Leaders

Bright Minds Biosciences
-- Review of Phase I ready BMB-101 and upcoming milestones -- -- Conference call to be held on May 19, 2022, 10:00am ET -- VANCOUVER, British Columbia, April 19, 2022 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted t... Read More...
857 views4 min read

Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

Revive Therapeutics
TORONTO, April 18, 2022 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today announced the publication of a scientific article evaluating the impact of medicati... Read More...
1363 views6 min read

Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT

Cybin
- Delivery of CYB004 via inhalation showed significant advantages over intravenously administered dimethyltryptamine ("IV DMT") in preclinical studies --- Rapid onset, longer duration of action and similar low variability achieved with single inhalation of CYB004 compared with IV DMT –- Inhaled CYB004 demonstrated more than 40% improved b... Read More...
1410 views7 min read

Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds

Delic Holdings
Federally-licensed research lab received additional 56 Research Exemption to acquire psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc. VANCOUVER, BC, April 13, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced tha... Read More...
974 views8 min read

Red Light Holland to Purchase 100 Acres of Farmland in Ontario, Canada as Its Mushroom Farms Division Expands in North America

Red Light Holland
Purchase of 100 acres farmland for $1.85 Million, in Ontario, Canada to close in June 2022Through experienced partners, Red Light's Farm Division plan on growing mushroom production with projected additional 65,000 sq feet of Mushroom production facilities Mike Medeiros (AEM Partner, Carleton Mushroom Farm co-owner and President of Mushro... Read More...
1144 views4 min read

Novamind Opens 8th Integrative Psychiatry Clinic

Novamind
New clinic in Phoenix, AZ, offers innovative mental health treatments and group therapyTORONTO, ON / ACCESSWIRE / April 6, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, today expanded its network to Phoenix, Arizona, with the opening of its eighth int... Read More...
1208 views5 min read

Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104

Field Trip Health
TORONTO, April 05, 2022 -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that the U.S. Patent and Trademark Office (“USPTO”) has granted the Company a patent for claims related to FT-104 (informally known as “Isoprocin Glutarate”),... Read More...
58 views7 min read

Allied Corp Commends Colombian Government for Announcing the Final Approval of the Regulations for the Export of Cannabis From Colombia

Allied
KELOWNA, British Columbia, April 04, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to commend the Colombian Government for the final approval of Regulation 227 (the "Regulation") which describes the technical guidelines regarding the export of cannabis flower from Colombia. On July 23, 2021, the President of Co... Read More...
599 views6 min read

Cybin Announces Initiation of Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain

Cybin
TORONTO, March 31, 2022--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing "Psychedelics to TherapeuticsTM", today announced that the first study visit has been conducted in a Cybin-sponsored feasibility study evaluating Kernel’s quantitative neuroimaging... Read More...
866 views3 min read

Silo Pharma Enters into Agreement with Contract Research Organization for Pharmacokinetic Study

Silo Pharma
ENGLEWOOD CLIFFS, N.J., March 31, 2022 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announces that it has entered into an agreement with Frontage Laboratories, a CRO (contract research organization), providing integrated, science-driven, produc... Read More...
846 views4 min read

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform

Entheon Biomedical
Improved Genetic Screening Platform to Strengthen Entheon's Psychedelic-Assisted ProtocolsVancouver, British Columbia--(Newsfile Corp. - March 29, 2022) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biomedical company focused on the research and development of psychedelic drugs and leadi... Read More...
104 views7 min read

Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003 Supporting Advancement into Phase 1/2a Clinical Trial

Cybin
-- IND-enabling safety pharmacology and toxicology studies completed in multiple species under GLP guidelines -- On track to submit IND to U.S. FDA in Q2 2022 for expected initiation of Phase 1/2a trial in mid-2022 --TORONTO, March 29, 2022--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceu... Read More...
863 views5 min read

Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants

Cybin
TORONTO, March 24, 2022--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing "Psychedelics to Therapeutics™", reports that its Company-sponsored feasibility study using Kernel’s quantitative neuroimaging technology, Kernel Flow, is actively recruiting p... Read More...
993 views4 min read

Novamind Expands Group Therapy Model

Novamind
Innovative in-person and virtual group offerings increase access to care and social connectionTORONTO, ON / ACCESSWIRE / March 24, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, announced today that it is launching Groups by Novamind, an expansion of t... Read More...
935 views2 min read

Pure Extracts Reaches 36 Product SKU Listings Across Canada

Pure Extracts Technologies
VANCOUVER, British Columbia, March 24, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that it has reached a total of 36 p... Read More...
1377 views8 min read

Delic Corp to Share Details of New Revenue Lines, Improved Outlook at Three Spring 2022 Investor Conferences

Delic Holdings
Matt Stang, Co-founder and CEO of Delic Corp, will outline the Company's strategic outlook for the remainder of the year at the Scottsdale Capital Event on April 22-24, Planet MicroCap Showcase on May 4, H.C. Wainwright Annual Global Life Sciences Conference on May 23-26 VANCOUVER, BC, March 23, 2022 - Delic Holdings Corp ("Delic") (CSE: ... Read More...
41 views8 min read

Red Light Holland Announces Mushroom Home Grow Kits Produced by Happy Caps Mushroom Farm Are Now Available for Purchase in 30 Retail Stores Across Canada

Red Light Holland
Toronto, Ontario--(Newsfile Corp. - March 22, 2022) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland"), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is extremely pleased to announc... Read More...
31 views10 min read

Red Light Holland Successfully Imports Psilocybin iMicrodose Packs into St. Vincent and the Grenadines Under a First-Ever Authorized Import Approval Process by the Country’s Bureau of Standards and the Ministry of Health

Red Light Holland
Red Light Holland's licensed subsidiary Scarlette Lillie Sciences and Innovation granted authorization for first ever psilocybin import into St. Vincent and the GrenadinesRed Light Holland's iMicrodose packs to be tested in preparation for further research with the goal of prescribed medical patient use in St. Vincent and the Grenadines R... Read More...
1078 views5 min read

Optimi Health Begins Cultivation Of Natural Psilocybin For Use In Clinical Trials

Optimi Health
Optimi Health Corp.VANCOUVER, British Columbia, March 18, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has commenced the cultivation of natural GMP-grade psilocybin mushrooms at its Princeton, British Columbia facility.“These mushrooms are an important milest... Read More...
788 views5 min read

Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.

HAVN Life Sciences
20/20 Global, Inc.Mycotopia Therapies plans to distribute HAVN’s line of natural OTC health products currently being registered with the Jamaican Ministry of HealthMIAMI, March 17, 2022 -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychede... Read More...
374 views8 min read

Allied Corp Files for Full Psilocybin Patent for Psilonex™ Rx Pharmaceutical

Allied
KELOWNA, British Columbia, March 16, 2022 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce that it has successfully filed for a full patent regarding “DOSING REGIMES OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH”. Due to... Read More...
887 views3 min read

Pure Extracts Exports First Shipment of Cannabis Oil Extracts to German Pharma Company

Pure Extracts Technologies
VANCOUVER, British Columbia, March 16, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that it has successfully exported i... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!